ArticleDermatology and therapy2025

Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?

Eric L Simpson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.